Danazol improves thrombocytopenia in HCV patients treated with peginterferon and ribavirin

Danazol improves thrombocytopenia in HCV patients treated with peginterferon and ribavirin

Background. Thrombocytopenia is a common hematologic disorder observed in patients with chronic hepatitis C virus (HCV) infection. Combined peginterferon (PEG-INF) and ribavirin treatment may exacerbate thrombocytopenia in patients with HCV.Objective. The aim of this pilot clinical trial was to asse...

Full description

Bibliographic Details
Main Authors: Guillermo Cabrera Álvarez, Diana Gόmez-Galicia, Lourdes Rodríguez-Fragoso, Vicente Madrid Marina, Luis Cañedo Dorantes, Miguel Sánchez-Alemán, Nahum Méndez-Sánchez, Jorge Reyes Esparza
Format: Article
Language:English
Published: Elsevier 2011-10-01
Series:Annals of Hepatology
Subjects:
Platelets
Antiviral therapy
Chronic hepatitis
Viral hepatitis
Sustained viral response
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119315133

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119315133

Similar Items